ETFs Holding CBPO »    CBPO Historical Stock Prices »
CBPO News Video: Thu, Apr 25, 2019, 4:16 PM — Daily Dividend Report: JNJ, BLL, MMP, AMP, AVY, BAC

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
China Biologic Products is a biopharmaceutical company engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. Co.'s principal products are human albumin and immunoglobulin for intravenous injection (IVIG). Human albumin is principally used to treat ill patients by replacing lost fluid and maintaining adequate blood volume and pressure. IVIG products are used to improve specific immunity, a defense mechanism by which the human body generates certain immunoglobulin, or antibodies, against invasion by potentially dangerous substances. All of Co.'s products are prescription medicines administered in the form of injections. Self directed investors in China Biologic Products Holdings Inc will be interested in keeping up with all China Biologic Products Holdings Inc news they can find, both CBPO news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on CBPO. At RediNews, we simplify this task by presenting both CBPO news releases originating from China Biologic Products Holdings Inc itself, and CBPO news from a variety of media outlets. Visitors can browse this news online and through our CBPO RSS news feed.


CBPO News — Articles, Videos, & Press Releases

First Week of May 17th Options Trading For China Biologic Products Holdings (CBPO)
Wednesday, April 10, 2019, 10:50 AM — Stock Options Channel
New Strong Sell Stocks for April 9th
Tuesday, April 9, 2019, 5:26 AM — Zacks
Noteworthy ETF Inflows: VWO, YY, CBPO, HOLI
Wednesday, April 3, 2019, 10:54 AM — ETF Channel
New Strong Sell Stocks for March 22nd
Friday, March 22, 2019, 2:10 AM — Zacks
New Strong Sell Stocks for March 20th
Wednesday, March 20, 2019, 5:23 AM — Zacks
New Strong Sell Stocks for March 18th
Monday, March 18, 2019, 8:47 AM — Zacks
CBPO Makes Bullish Cross Above Critical Moving Average
Tuesday, March 5, 2019, 11:35 AM — Market News Video
Analysts Expect 40% Upside For FNI
Wednesday, October 24, 2018, 7:37 AM — ETF Channel
China Biologic Products Holdings (CBPO) Shares Cross Below 200 DMA
Friday, August 24, 2018, 11:36 AM — Market News Video
CBPO Crosses Above Average Analyst Target
Wednesday, August 8, 2018, 7:38 AM — ETF Channel
First Week of August 17th Options Trading For China Biologic Products Holdings (CBPO)
Wednesday, June 20, 2018, 11:14 AM — Stock Options Channel
China Biologic Products Holdings Reaches Analyst Target Price
Tuesday, June 19, 2018, 7:50 AM — ETF Channel
CBPO Makes Bullish Cross Above Critical Moving Average
Wednesday, May 30, 2018, 12:01 PM — Market News Video
Analysts Forecast 15% Gains Ahead For The Holdings of FNI
Tuesday, May 15, 2018, 9:19 AM — ETF Channel
CBPO is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


RediNews invites financial news content websites to integrate our XML content for web sites by integrating our RSS feeds found throughout our website wherever news and stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic content is ideal for any financial portal or web portal, from business content web sites to corporate portal intranets. Let RediNews be your content provider of free financial content for news, perfect for location on stock market chart pages by symbol, adding another element of dynamic stock market content to your financial portal. If your web page content already includes elements like SEC filings, screener pages, historical chart information, and other cobranded financial web content, then headlines from RediNews can supplement this dynamic financial content meaningfully.

CBPO News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.